Profile: Mesoblast Ltd (MSB.AX)

MSB.AX on Australia Stock Exchange

4.26AUD
22 Aug 2014
Price Change (% chg)

$0.05 (+1.19%)
Prev Close
$4.21
Open
$4.22
Day's High
$4.29
Day's Low
$4.18
Volume
653,968
Avg. Vol
414,001
52-wk High
$6.80
52-wk Low
$3.91

Search Stocks
Mesoblast Limited (Mesoblast) is a clinical development company leveraging its core technologies, which include the Mesenchymal Precursor Cell (MPC) technology platform for bone marrow and adipose tissue derived products, Dental Pulp Stem Cells (DPSCs), and expanded Hematopoietic Stem Cells (HSCs). The Company’s cardiovascular and neurologic product pipeline is being developed in partnership with Teva Pharmaceutical Industries Ltd (Teva). The Company’s subsidiaries include Mesoblast, Inc., Mesoblast International SA, Mesoblast Australia Pty Ltd and Mesoblast UK Limited.

Company Address

Mesoblast Ltd

Level 39, 55 Collins Street
MELBOURNE   VIC   3000
P: +613.96396036
F: +613.96396030

Search Stocks